Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01663207 · ClinicalTrials.gov registry record
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
A clinical trial, sponsored by Foundation for the National Institutes of Health.
- Completed
- Registry status
- 20
- Enrollment target
NCT01663207: Completed study, sponsored by Foundation for the National Institutes of Health.
NCT01663207 is a clinical trial that has completed, run by Foundation for the National Institutes of Health. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01663207 has completed, sponsored by Foundation for the National Institutes of Health.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
A multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mellitus.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-04 |
What the finished NCT01663207 record still lists
NCT01663207 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01663207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01663207 about?
NCT01663207 is a clinical study titled "Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes". A multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mellitus.
What is the current status of trial NCT01663207?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01663207?
This trial is sponsored by Foundation for the National Institutes of Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia